Ar-Rahman Pharm LLC
FDA and FTC jointly issued a warning letter to Ar-Rahman Pharm LLC (Abdur-Rahmaan Felder) in September 2021 regarding its 'Diabetes Support' dietary supplement. The agencies found that website and social media claims—asserting the product balances blood sugar, supports insulin/glucagon, and manages diabetes—rendered the product an unapproved new drug under the FD&C Act and a misbranded drug lacking adequate directions for use. The FTC simultaneously issued a cease-and-desist demand for unsubstantiated disease-treatment claims, warning of potential civil penalties up to $43,792 per violation and possible consumer redress.
Flagged claims (5)
Herbs such as those in our Diabetes support formula have been scientifically shown to support healthy blood sugar levels.
May help balance Blood Sugar Levels
DIABETES SUPPORT (your product name) . . . Diabetes is caused when the body either resists insulin or does not produce enough; either of which can lead to unbalanced blood glucose levels. Our diabetes support formula assists in keeping blood sugar at an optimum level. ..... Diabetes Support helps to balance blood glucose levels.
Provide supplemental nutrients to the pancreas for balancing insulin and glucagon.
Our diabetes support formula assists in keeping blood sugar at an optimum level. This wonderful blend . . . makes blood sugar management easier. With nutrient dense herbs . . . Diabetes Support helps to balance blood glucose levels.
Required actions (6)
Please notify FDA in writing, within 15 working days of receipt of this letter of the specific steps you have taken to address any violations.
Notice is hereby given that you must cease and desist from making any claim that a product and prevent, treat, or cure diabetes without competent and reliable scientific evidence consisting of well-controlled human clinical studies substantiating that the claims are true.
please notify Richard Cleland of the FTC via electronic mail at [email protected] within fifteen (15) working days of receipt of this letter of the specific actions you have taken to address FTC's concerns.
marketers who make deceptive claims about the treatment, cure, prevention, or mitigation of a disease may be subject to a civil penalty of up to $43,792 per violation pursuant to Section 5(m)(1)(B) of the FTC Act
may be required to pay refunds to consumers or provide other relief pursuant to Section 19(b) of the FTC Act, 15 U.S.C. § 57b(b).
Failure to adequately address these matters may result in legal action including, without limitation, seizure and injunction.
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most nutrition / supplements sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker